• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种结合放射组学和临床特征的列线图作为预测肺腺癌脏层胸膜侵犯的影像生物标志物

A Nomogram Combined Radiomics and Clinical Features as Imaging Biomarkers for Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma.

作者信息

Zha Xinyi, Liu Yuanqing, Ping Xiaoxia, Bao Jiayi, Wu Qian, Hu Su, Hu Chunhong

机构信息

Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Institute of Medical Imaging, Soochow University, Suzhou, China.

出版信息

Front Oncol. 2022 May 25;12:876264. doi: 10.3389/fonc.2022.876264. eCollection 2022.

DOI:10.3389/fonc.2022.876264
PMID:35692792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9174422/
Abstract

OBJECTIVES

To develop and validate a nomogram model based on radiomics features for preoperative prediction of visceral pleural invasion (VPI) in patients with lung adenocarcinoma.

METHODS

A total of 659 patients with surgically pathologically confirmed lung adenocarcinoma underwent CT examination. All cases were divided into a training cohort (n = 466) and a validation cohort (n = 193). CT features were analyzed by two chest radiologists. CT radiomics features were extracted from CT images. LASSO regression analysis was applied to determine the most useful radiomics features and construct radiomics score (radscore). A nomogram model was developed by combining the optimal clinical and CT features and the radscore. The model performance was evaluated using ROC analysis, calibration curve and decision curve analysis (DCA).

RESULTS

A total of 1316 radiomics features were extracted. A radiomics signature model with a selection of the six optimal features was developed to identify patients with or without VPI. There was a significant difference in the radscore between the two groups of patients. Five clinical features were retained and contributed as clinical feature models. The nomogram combining clinical features and radiomics features showed improved accuracy, specificity, positive predictive value, and AUC for predicting VPI, compared to the radiomics model alone (specificity: training cohort: 0.89, validation cohort: 0.88, accuracy: training cohort: 0.84, validation cohort: 0.83, AUC: training cohort: 0.89, validation cohort: 0.89). The calibration curve and decision curve analyses suggested that the nomogram with clinical features is beyond the traditional clinical and radiomics features.

CONCLUSION

A nomogram model combining radiomics and clinical features is effective in non-invasively prediction of VPI in patients with lung adenocarcinoma.

摘要

目的

基于影像组学特征开发并验证一种列线图模型,用于术前预测肺腺癌患者的脏层胸膜侵犯(VPI)。

方法

共有659例经手术病理确诊的肺腺癌患者接受了CT检查。所有病例分为训练队列(n = 466)和验证队列(n = 193)。由两名胸部放射科医生分析CT特征。从CT图像中提取CT影像组学特征。应用LASSO回归分析确定最有用的影像组学特征并构建影像组学评分(radscore)。通过结合最佳临床和CT特征以及radscore开发列线图模型。使用ROC分析、校准曲线和决策曲线分析(DCA)评估模型性能。

结果

共提取了1316个影像组学特征。开发了一种选择六个最佳特征的影像组学特征模型,以识别有无VPI的患者。两组患者的radscore存在显著差异。保留了五个临床特征并作为临床特征模型。与单独的影像组学模型相比,结合临床特征和影像组学特征的列线图在预测VPI方面显示出更高的准确性、特异性、阳性预测值和AUC(特异性:训练队列:0.89,验证队列:0.88;准确性:训练队列:0.84,验证队列:0.83;AUC:训练队列:0.89,验证队列:0.89)。校准曲线和决策曲线分析表明,具有临床特征的列线图优于传统的临床和影像组学特征。

结论

结合影像组学和临床特征的列线图模型可有效无创预测肺腺癌患者的VPI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/c02a33a82edf/fonc-12-876264-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/acd264c3af38/fonc-12-876264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/be1d6a1d39aa/fonc-12-876264-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/99528b610e31/fonc-12-876264-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/f7362b8dfbc7/fonc-12-876264-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/c02a33a82edf/fonc-12-876264-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/acd264c3af38/fonc-12-876264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/be1d6a1d39aa/fonc-12-876264-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/99528b610e31/fonc-12-876264-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/f7362b8dfbc7/fonc-12-876264-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbd/9174422/c02a33a82edf/fonc-12-876264-g005.jpg

相似文献

1
A Nomogram Combined Radiomics and Clinical Features as Imaging Biomarkers for Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma.一种结合放射组学和临床特征的列线图作为预测肺腺癌脏层胸膜侵犯的影像生物标志物
Front Oncol. 2022 May 25;12:876264. doi: 10.3389/fonc.2022.876264. eCollection 2022.
2
CT-based radiomics nomogram for predicting visceral pleural invasion in peripheral T1-sized solid lung adenocarcinoma.基于CT的影像组学列线图预测周围型T1期实性肺腺癌的脏层胸膜侵犯情况
Am J Cancer Res. 2023 Dec 15;13(12):5901-5913. eCollection 2023.
3
Predicting visceral pleural invasion in lung adenocarcinoma presenting as part-solid density utilizing a nomogram model combined with radiomics and clinical features.利用列线图模型联合放射组学和临床特征预测表现为部分实性密度的肺腺癌的内脏胸膜侵犯。
Thorac Cancer. 2024 Jan;15(1):23-34. doi: 10.1111/1759-7714.15151. Epub 2023 Nov 28.
4
Nomogram using intratumoral and peritumoral radiomics for the preoperative prediction of visceral pleural invasion in clinical stage IA lung adenocarcinoma.基于肿瘤内和肿瘤周围放射组学的Nomogram 模型,用于术前预测临床ⅠA 期肺腺癌内脏胸膜侵犯。
J Cardiothorac Surg. 2024 May 31;19(1):307. doi: 10.1186/s13019-024-02807-7.
5
Development and validation of F-FDG PET/CT radiomics-based nomogram to predict visceral pleural invasion in solid lung adenocarcinoma.基于F-FDG PET/CT影像组学的列线图预测实性肺腺癌脏层胸膜侵犯的开发与验证
Ann Nucl Med. 2023 Nov;37(11):605-617. doi: 10.1007/s12149-023-01861-w. Epub 2023 Aug 20.
6
Multi-Phase CT-Based Radiomics Nomogram for Discrimination Between Pancreatic Serous Cystic Neoplasm From Mucinous Cystic Neoplasm.基于多期CT的影像组学列线图在鉴别胰腺浆液性囊性肿瘤与黏液性囊性肿瘤中的应用
Front Oncol. 2021 Dec 1;11:699812. doi: 10.3389/fonc.2021.699812. eCollection 2021.
7
Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.基于肝胆期成像预测磷脂酰肌醇蛋白聚糖-3阳性肝细胞癌的影像组学列线图
Front Oncol. 2023 Sep 29;13:1209814. doi: 10.3389/fonc.2023.1209814. eCollection 2023.
8
Multivariate analysis based on the maximum standard unit value of F-fluorodeoxyglucose positron emission tomography/computed tomography and computed tomography features for preoperative predicting of visceral pleural invasion in patients with subpleural clinical stage IA peripheral lung adenocarcinoma.基于 F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描最大标准单位值和计算机断层扫描特征的多变量分析,用于术前预测亚胸膜临床分期 IA 周围型肺腺癌患者内脏胸膜侵犯。
Diagn Interv Radiol. 2023 Mar 29;29(2):379-389. doi: 10.4274/dir.2023.222006. Epub 2023 Feb 21.
9
A CT-Based Radiomics Nomogram Combined with Clinic-Radiological Characteristics for Preoperative Prediction of the Novel IASLC Grading of Invasive Pulmonary Adenocarcinoma.基于 CT 的放射组学列线图结合临床影像学特征对新型 IASLC 浸润性肺腺癌分级的术前预测。
Acad Radiol. 2023 Sep;30(9):1946-1961. doi: 10.1016/j.acra.2022.12.006. Epub 2022 Dec 24.
10
Multi-dimensional radiomics analysis to predict visceral pleural invasion in lung adenocarcinoma of ≤3 cm maximum diameter.多维度放射组学分析预测最大直径≤3 cm的肺腺癌脏层胸膜侵犯情况。
Clin Radiol. 2023 Nov;78(11):e847-e855. doi: 10.1016/j.crad.2023.07.014. Epub 2023 Aug 3.

引用本文的文献

1
A nomogram model integrating radiomics and clinical variables to predict napsin a expression in lung adenocarcinoma patients.一种整合影像组学和临床变量的列线图模型,用于预测肺腺癌患者中的 napsin a 表达。
Front Oncol. 2025 Jul 4;15:1595406. doi: 10.3389/fonc.2025.1595406. eCollection 2025.
2
Consensus clustering based on CT radiomics has potential for risk stratification of patients with clinical T1 stage lung adenocarcinoma.基于CT影像组学的一致性聚类在临床T1期肺腺癌患者的风险分层中具有潜力。
BMC Med Imaging. 2025 Jul 1;25(1):231. doi: 10.1186/s12880-025-01795-x.
3
Deep learning radiomics fusion model to predict visceral pleural invasion of clinical stage IA lung adenocarcinoma: a multicenter study.

本文引用的文献

1
Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy.基于影像组学特征的列线图:一种预测表皮生长因子受体激活突变以指导表皮生长因子受体酪氨酸激酶抑制剂治疗的新技术。
Front Oncol. 2021 Aug 6;11:590937. doi: 10.3389/fonc.2021.590937. eCollection 2021.
2
Visceral Pleural Invasion in Pulmonary Adenocarcinoma: Differences in CT Patterns between Solid and Subsolid Cancers.肺腺癌的脏层胸膜侵犯:实性癌与亚实性癌CT表现的差异
Radiol Cardiothorac Imaging. 2019 Aug 29;1(3):e190071. doi: 10.1148/ryct.2019190071. eCollection 2019 Aug.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
用于预测临床ⅠA期肺腺癌脏层胸膜侵犯的深度学习影像组学融合模型:一项多中心研究
J Cardiothorac Surg. 2025 May 28;20(1):246. doi: 10.1186/s13019-025-03488-6.
4
Development and validation of a nomogram for predicting visceral pleural invasion in patients with early-stage non-small cell lung cancer.预测早期非小细胞肺癌患者脏层胸膜侵犯的列线图的开发与验证
Transl Lung Cancer Res. 2024 Dec 31;13(12):3352-3363. doi: 10.21037/tlcr-24-459. Epub 2024 Dec 27.
5
Risk analysis of visceral pleural invasion in malignant solitary pulmonary nodules that appear touching the pleural surface.恶性孤立性肺结节与胸膜接触时脏层胸膜侵犯的风险分析。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241285606. doi: 10.1177/17534666241285606.
6
CT-based radiomic consensus clustering association with tumor biological behavior in clinical stage IA adenocarcinoma: a retrospective study.基于CT的影像组学共识聚类与临床I A期腺癌肿瘤生物学行为的相关性:一项回顾性研究
Transl Lung Cancer Res. 2024 Aug 31;13(8):1794-1806. doi: 10.21037/tlcr-24-283. Epub 2024 Aug 12.
7
Nomogram using intratumoral and peritumoral radiomics for the preoperative prediction of visceral pleural invasion in clinical stage IA lung adenocarcinoma.基于肿瘤内和肿瘤周围放射组学的Nomogram 模型,用于术前预测临床ⅠA 期肺腺癌内脏胸膜侵犯。
J Cardiothorac Surg. 2024 May 31;19(1):307. doi: 10.1186/s13019-024-02807-7.
8
Research progress in predicting visceral pleural invasion of lung cancer: a narrative review.预测肺癌脏层胸膜侵犯的研究进展:一项叙述性综述
Transl Cancer Res. 2024 Jan 31;13(1):462-470. doi: 10.21037/tcr-23-1318. Epub 2023 Dec 26.
9
CT-based radiomics nomogram for predicting visceral pleural invasion in peripheral T1-sized solid lung adenocarcinoma.基于CT的影像组学列线图预测周围型T1期实性肺腺癌的脏层胸膜侵犯情况
Am J Cancer Res. 2023 Dec 15;13(12):5901-5913. eCollection 2023.
10
Predicting visceral pleural invasion in lung adenocarcinoma presenting as part-solid density utilizing a nomogram model combined with radiomics and clinical features.利用列线图模型联合放射组学和临床特征预测表现为部分实性密度的肺腺癌的内脏胸膜侵犯。
Thorac Cancer. 2024 Jan;15(1):23-34. doi: 10.1111/1759-7714.15151. Epub 2023 Nov 28.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual.根据美国癌症联合委员会(AJCC)第8版分期手册对IB期非小细胞肺癌患者进行分层。
Front Oncol. 2020 Apr 21;10:571. doi: 10.3389/fonc.2020.00571. eCollection 2020.
5
A simple, step-by-step guide to interpreting decision curve analysis.解读决策曲线分析的简易分步指南。
Diagn Progn Res. 2019 Oct 4;3:18. doi: 10.1186/s41512-019-0064-7. eCollection 2019.
6
Clinical Significance of Pleural Attachment and Indentation of Subsolid Nodule Lung Cancer.实性肺小结节肺癌胸膜附着和凹陷的临床意义。
Cancer Res Treat. 2019 Oct;51(4):1540-1548. doi: 10.4143/crt.2019.057. Epub 2019 Mar 25.
7
The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges.放射组学在肿瘤精准诊断与治疗中的应用:机遇与挑战。
Theranostics. 2019 Feb 12;9(5):1303-1322. doi: 10.7150/thno.30309. eCollection 2019.
8
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.深度学习在肺癌预后预测中的应用:一项回顾性多队列放射组学研究。
PLoS Med. 2018 Nov 30;15(11):e1002711. doi: 10.1371/journal.pmed.1002711. eCollection 2018 Nov.
9
Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer.非小细胞肺癌反应和结果评估的放射组学
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818782788. doi: 10.1177/1533033818782788.
10
Prognostic Impact of the Findings on Thin-Section Computed Tomography in stage I lung adenocarcinoma with visceral pleural invasion.Ⅰ期伴有内脏胸膜侵犯肺腺癌中薄层 CT 所见对预后的影响。
Sci Rep. 2018 Mar 16;8(1):4743. doi: 10.1038/s41598-018-22853-1.